AIkido Pharma Inc. focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for prostate cancer,pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses.
